{"url_path":"/sec/cycn/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1755237/0001193125-26-219478-index.html","accession_number":"0001193125-26-219478","cik":"0001755237","ticker":"CYCN","issuer_name":"Korsana Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1755237/0001193125-26-219478-index.html","primary_entity_key":"0001755237","primary_entity_name":"Cyclerion Therapeutics, Inc."},"word_count":46,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nWe are not a party to any material legal proceedings at this time. From time to time, we may be subject to various legal proceedings and claims, which may have a material adverse effect on our financial position or results of operations."}